Short-term and long-term outcomes in living donors for liver transplantation: Cohort study

Kosei Takagi1, Yuzo Umeda1, Ryuichi Yoshida1

  • 1Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

Insights

Short-term outcomes for living liver donors have improved, but long-term follow-up is crucial. Donor hepatectomy (DH) complications are manageable, yet donors may develop comorbidities later.

Area of Science:

  • Hepatobiliary Surgery
  • Transplantation Medicine
  • Surgical Outcomes Research

Background:

  • Limited data exists on long-term outcomes for living donors after donor hepatectomy (DH).
  • Perioperative outcomes of DH have been documented, but long-term donor health remains understudied.

Purpose of the Study:

  • To investigate both short-term and long-term outcomes in living donors following donor hepatectomy (DH).

Main Methods:

  • Retrospective analysis of 408 living donors who underwent DH between 1996 and 2019.
  • Evaluation of short-term outcomes based on surgical era and graft type.
  • Assessment of long-term outcomes including surgery-related complications and comorbidities.

Main Results:

  • Overall postoperative complication rate was 40.4% (minor 30.4%, major 10.0%, biliary 14.0%).
  • Short-term outcomes showed slight improvement over time, with no significant difference between graft types.
  • Long-term follow-up (median 7.2 years) revealed a 6.6% incidence of surgery-related complications and development of comorbidities like lifestyle diseases and cancers.

Conclusions:

  • Perioperative outcomes for living donors have improved.
  • Graft type does not significantly impact postoperative outcomes.
  • Living donors are susceptible to various morbidities during long-term follow-up, necessitating careful management and ongoing monitoring.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
177
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
172
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
741